EN
Instrument Fundamentals
| Date | Close | Change | Change (%) | Open | High | Low |
|---|
News
Ritholtz Wealth Management Increases Stock Position in Gilead Sciences, Inc. $GILD - Markets Daily
Gilead Sciences, Inc. $GILD Shares Purchased by Ritholtz Wealth Management - Stock Observer
Morgan Stanley Cuts Gilead Sciences (NASDAQ:GILD) Price Target to $150.00 - Daily Political
Gilead Sciences, Inc. $GILD Shares Sold by Conning Inc.
Has Gilead Sciences (GILD) Moved Too Far After Strong Multi‑Year Share Price Gains
A Look At Gilead Sciences (GILD) Valuation After JP Morgan Conference HIV Pipeline Update
Morgan Stanley Issues Pessimistic Forecast for Gilead Sciences (NASDAQ:GILD) Stock Price
Gilead Sciences, Inc. $GILD Shares Acquired by TD Private Client Wealth LLC
Liberty One Investment Management LLC Increases Stake in Gilead Sciences, Inc. $GILD
Polaris Capital Management LLC Sells 12,500 Shares of Gilead Sciences, Inc. $GILD
Gilead Sciences, Inc. $GILD Shares Acquired by PKO Investment Management Joint Stock Co
Analysts Offer Insights on Healthcare Companies: Biodesix (BDSX), Gilead Sciences (GILD) and Agios Pharma (AGIO) | Markets Insider
Linavonkibart and pembrolizumab in immune checkpoint blockade-resistant advanced solid tumors: a phase 1 trial
Meeder Asset Management Inc. Has $16.76 Million Position in Gilead Sciences, Inc. $GILD - Markets Daily
Sumitomo Mitsui Trust Group Inc. Buys 27,232 Shares of Gilead Sciences, Inc. $GILD
Nexus Investment Management ULC Buys 21,220 Shares of Gilead Sciences, Inc. $GILD
9,809 Shares in Gilead Sciences, Inc. $GILD Bought by Elite Wealth Management Inc.
UBS and Citi Go Bullish on Gilead Sciences (GILD)
Meeder Asset Management Inc. Has $16.76 Million Stock Holdings in Gilead Sciences, Inc. $GILD - Stock Observer
Sumitomo Mitsui Trust Group Inc. Has $369.58 Million Stock Position in Gilead Sciences, Inc. $GILD - Stock Observer
Nexus Investment Management ULC Increases Position in Gilead Sciences, Inc. $GILD - Daily Political
Tema Etfs LLC Buys 25,912 Shares of Gilead Sciences, Inc. $GILD - Daily Political
Is Gilead Sciences (GILD) Pricing Reflecting Recent 38.5% One Year Share Return?
HB Wealth Management LLC Buys 13,249 Shares of Gilead Sciences, Inc. $GILD
Gilead Sciences (NASDAQ:GILD) Research Coverage Started at UBS Group - Markets Daily
Oregon Public Employees Retirement Fund Acquires 34,235 Shares of Gilead Sciences, Inc. $GILD - Daily Political
Gilead Sciences, Inc. $GILD Position Lessened by Capital Investment Advisors LLC
11 Most Undervalued Blue Chip Stocks to Buy Now
Hennion & Walsh Asset Management Inc. Increases Position in Gilead Sciences, Inc. $GILD - Daily Political
Patient advocates urge U.S. court to halt AFP prescription operations
GILD: HIV PrEP Strength And Oncology Mixed Results Will Shape Outlook
What Gilead Sciences (GILD)'s OncoNano Drug-Encapsulation Deal Means For Shareholders
Citigroup Boosts Gilead Sciences (NASDAQ:GILD) Price Target to $140.00 - Daily Political
Assessing Gilead Sciences (GILD) Valuation After Recent Share Price Momentum
Gilead Sciences (NASDAQ:GILD) Given Buy Rating at UBS Group - Daily Political
Securian Asset Management Inc. Sells 5,084 Shares of Gilead Sciences, Inc. $GILD - Daily Political
Assessing Gilead Sciences (GILD) Valuation After Mixed Near Term Returns And 9.4% Undervaluation Estimate
11,480 Shares in Gilead Sciences, Inc. $GILD Bought by TriaGen Wealth Management LLC
Wall Street Zen Upgrades Gilead Sciences (NASDAQ:GILD) to "Strong-Buy" - Zolmax
Gateway Investment Advisers LLC Raises Stock Position in Gilead Sciences, Inc. $GILD
SteelPeak Wealth LLC Sells 94,279 Shares of Gilead Sciences, Inc. $GILD
Gilead Sciences, Inc. $GILD Shares Purchased by Asset Management One Co. Ltd.
Gilead Sciences, Inc. $GILD Stock Position Lifted by Allspring Global Investments Holdings LLC
Gilead Sciences, Inc. $GILD is Verity & Verity LLC's 10th Largest Position - Daily Political
Gilead Sciences (NASDAQ:GILD) Upgraded to "Strong-Buy" at Wall Street Zen
Binimetinib and encorafenib for the treatment of advanced solid tumors with non-V600E BRAF mutations: results from the Phase II BEAVER trial
Bank Pictet & Cie Europe AG Boosts Holdings in Gilead Sciences, Inc. $GILD
Gilead Sciences Q3 EPS Forecast Raised by Zacks Research
Morgan Stanley Expects Gilead Sciences (GILD) to Thrive as Biopharma Policy Uncertainties Fade in 2026
Lee Johnson Capital Management LLC Makes New Investment in Gilead Sciences, Inc. $GILD
Ascent Group LLC Buys 11,926 Shares of Gilead Sciences, Inc. $GILD
Gilead (GILD) Reaches Pricing Agreement with US Government to Lower Drug Costs
Daniel Patrick O'day Sells 10,000 Shares of Gilead Sciences (NASDAQ:GILD) Stock
Google's Marc Berson appointed to Mastek Inc's Board of Directors
Diversified Trust Co Increases Holdings in Gilead Sciences, Inc. $GILD
Abacus FCF Advisors LLC Reduces Holdings in Gilead Sciences, Inc. $GILD
Is Gilead Sciences (GILD) An Affordable Healthcare Stocks to Invest In?
14 Best Pharma Dividend Stocks to Buy in 2026
Long-Term Stock Portfolio: 10 Best Stocks for the Next Decade
Sapient Capital LLC Sells 8,077 Shares of Gilead Sciences, Inc. $GILD
Gilead Sciences, Inc. $GILD Shares Bought by E. Ohman J or Asset Management AB
Meyer Handelman Co. Has $38.56 Million Stock Holdings in Gilead Sciences, Inc. $GILD
Highland Capital Management LLC Invests $1.76 Million in Gilead Sciences, Inc. $GILD
Meyer Handelman Co. Trims Stock Holdings in Gilead Sciences, Inc. $GILD - Stock Observer
Expression of antibody-drug conjugate targets in post-mortem samples of breast cancer metastases and normal tissue
Norden Group LLC Has $3.40 Million Stock Holdings in Gilead Sciences, Inc. $GILD
Gilead Sciences, Inc. (NASDAQ:GILD) Receives Average Recommendation of "Moderate Buy" from Brokerages
Does Gilead's 2025 Rally Match Its Cash Flow Outlook and Oncology Pipeline Prospects
Repare Therapeutics Announces Acquisition of Polθ ATPase Inhibitor, RP-3467, by Gilead Sciences for Up To $30 Million in Total Consideration
Repare Therapeutics Sells Polymerase Theta ATPase Inhibitor To Gilead For Up To $30Mln
Repare Therapeutics Shares Rise on $30 Million Asset Deal With Gilead | Morningstar
CAMBRIDGE, Mass. & MONTREAL -- (Business Wire) Repare T
Global X Japan Co. Ltd. Acquires 11,034 Shares of Gilead Sciences, Inc. $GILD
Vontobel Holding Ltd. Acquires 394,567 Shares of Gilead Sciences, Inc. $GILD - Daily Political
Exchange Traded Concepts LLC Boosts Stock Position in Gilead Sciences, Inc. $GILD
OFI Invest Asset Management Has $42.01 Million Position in Gilead Sciences, Inc. $GILD - Daily Political
Gilead Sciences, Inc. $GILD Holdings Reduced by U.S. Capital Wealth Advisors LLC - Daily Political
Wall Street Zen Downgrades Gilead Sciences (NASDAQ:GILD) to Buy - Markets Daily
Wedge Capital Management L L P NC Sells 59,085 Shares of Gilead Sciences, Inc. $GILD
First Bank & Trust Sells 4,494 Shares of Gilead Sciences, Inc. $GILD - Daily Political
GILD: Extended HIV Exclusivity Will Support Stronger Long-Term Earnings Power
Gilead (GILD): Revisiting Valuation After HIV Wins and New U.S. Drug Pricing Agreement
Gilead Sciences (NASDAQ:GILD) Cut to "Buy" at Wall Street Zen
TrumpRx explained: How Trump's new drug price deals with 9 pharma companies could save patients money
Mechanisms of resistance to trastuzumab deruxtecan in breast cancer elucidated by multi-omic molecular profiling
Novel treatment strategies and key research priorities for patients with breast cancer and central nervous system (CNS) metastases
Agreement addresses all requests by President Trump to reduc
Gilead and U.S. Government Enter Agreement to Lower Costs of Medicines for Americans
Gilead news
Latest news
Show more
Global Market Review: Gold Volatility and Tech Stock Surge Amidst Economic Uncertainty
September CPI Data: Inflation Hurdles, Tariff Impacts, and Fed Rate Cut Expectations
Navigating the AI Boom: Strategies for Investors Amid Nvidia's Valuation Surge
